Compound Profile: Exos Pharmacom
Exos Pharmacom is a pharmaceutical-grade exemestane formulation designed for advanced endocrine research applications. Exemestane is a Type I irreversible aromatase inhibitor that provides researchers at Stroid UK Shop with a potent tool for examining estrogen biosynthesis pathways and hormonal regulation mechanisms. This steroidal aromatase inhibitor works through covalent binding to the aromatase enzyme active site, enabling detailed investigation of estrogen-dependent processes in controlled laboratory conditions.
Laboratory Applications
Research scientists utilise Exos Pharmacom to examine aromatase enzyme kinetics and estrogen receptor signalling pathways across diverse experimental models. The compound’s irreversible inhibition mechanism makes it valuable for studying long-term estrogen suppression effects in cellular and tissue cultures. Researchers investigating endocrine disruption, hormone-dependent cancer cell lines, and reproductive biology frequently incorporate exemestane into their protocols. The formulation enables comprehensive analysis of estrogen-mediated gene expression changes and downstream metabolic effects in various research contexts. Studies examining aromatase inhibitor mechanisms benefit from exemestane’s well-characterised pharmacokinetic profile and extensive literature foundation.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Exemestane |
| CAS Number | 107868-30-4 |
| Molecular Formula | C₂₀H₂₄O₂ |
| Molecular Weight | 296.4 g/mol |
| Mechanism | Irreversible aromatase inhibitor |
| Storage | Room temperature, dry conditions |
Researchers conducting comparative studies with other research compounds often cross-reference exemestane protocols with selective androgen receptor modulators and peptide formulations to understand complex hormonal interactions in experimental systems.
Research Compliance
Exos Pharmacom is supplied exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must comply with institutional protocols and regulatory requirements when handling this research compound.
